Artwork
iconShare
 
Manage episode 518780435 series 2514024
Content provided by KPBS. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by KPBS or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Scientists at Scripps Research recently launched a new clinical trial that will test if a repurposed GLP-1 drug, tirzepatide, can provide possible relief for long COVID symptoms.Monday on Midday Edition, we sit down with Dr. Eric Topol to hear more about the trial and the state of long COVID research and treatment today.Guest:Dr. Eric Topol, executive vice president, Scripps Research Translational InstituteResources: Long COVID Treatment Trial — Scripps Research

  continue reading

1281 episodes